HR 4124
National Biomedical Research Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The National Biomedical Research Act establishes the Biomedical Innovation Fund, which will receive $10 billion annually from the Treasury Department through 2031. This fund is intended to support biomedical research at the National Institutes of Health and the Food and Drug Administration, focusing on disease prevention, treatment, and innovative medical products. The fund’s distribution will prioritize research addressing disproportionately high healthcare spending and early-career scientists, with a goal of fostering breakthrough discoveries and improving regulatory decision-making.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.